Company intelligence / Profile preview

Caribe Holdings

Sarasota, Florida, United States

Ownership: Private
Development stage: Other

Overview

The company claims to have commenced patient-funded adult stem cell therapies for degenerative diseases and some experimental brain trauma indications. Publicly reported treatment numbers were in the early rollout stage in 2014 (eight patients qualified, three treated in the DR), with anecdotal reports of improvement, but no formal Phase 1-3 clinical trial data or peer-reviewed summaries are disclosed[3].

Therapeutic areas: CardiovascularNeurologyEndocrinologyRheumatology
Modalities: Cell therapyStem cell therapy
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Caribe Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caribe Holdings.

Explore the full profile